International clinical psychopharmacology, Vol. 22, No. 6. (November 2007), pp. 338-347.
CNS spectrums, Vol. 13, No. 5. (May 2008), pp. 415-422.
The New England journal of medicine, Vol. 358, No. 20. (15 May 2008), pp. 2185-2186.
Digestive diseases and sciences, Vol. 48, No. 5. (May 2003), pp. 939-944.
Drug safety : an international journal of medical toxicology and drug experience, Vol. 31, No. 4. (2008), pp. 345-354.
Am J Psychiatry, Vol. 165, No. 3. (March 2008), pp. 342-351.
by M
Fava, AJ
Rush, JE
Alpert, GK
Balasubramani, SR
Wisniewski, CN
Carmin, MM
Biggs, S
Zisook, A
Leuchter, R
Howland, D
Warden, MH
Trivedi
Drug Saf, Vol. 31, No. 2. (2008), pp. 159-168.
Psychosomatics, Vol. 49, No. 1. (b 2008), pp. 84-85.
Br J Psychiatry, Vol. 192, No. 2. (February 2008), pp. 124-129.
N Engl J Med, Vol. 358, No. 3. (17 January 2008), pp. 252-260.
Arch Intern Med, Vol. 168, No. 2. (28 January 2008), pp. 180-185.
Arch Gen Psychiatry, Vol. 65, No. 1. (January 2008), pp. 38-46.
by DA
Barton, MD
Esler, T
Dawood, EA
Lambert, D
Haikerwal, C
Brenchley, F
Socratous, J
Hastings, L
Guo, G
Wiesner, DM
Kaye, R
Bayles, MP
Schlaich, GW
Lambert
Depress Anxiety, Vol. 14, No. 1. (2001), pp. 19-28.
Clin Ther, Vol. 29, No. 5. (May 2007), pp. 918-926.
Am J Psychiatry, Vol. 164, No. 9. (September 2007), pp. 1379-1384.
Clin Pharmacol Ther (11 July 2007)
N Engl J Med, Vol. 356, No. 26. (28 June 2007), pp. 2684-2692.
N Engl J Med, Vol. 356, No. 26. (28 June 2007), pp. 2675-2683.
Arch Intern Med, Vol. 167, No. 12. (25 June 2007), pp. 1240-1245.
Arch Intern Med, Vol. 167, No. 12. (25 June 2007), pp. 1246-1251.
Arch Gen Psychiatry, Vol. 64, No. 6. (June 2007), pp. 679-688.
by R
Cooper-Kazaz, JT
Apter, R
Cohen, L
Karagichev, S
Muhammed-Moussa, D
Grupper, T
Drori, ME
Newman, HA
Sackeim, B
Glaser, B
Lerer
JAMA, Vol. 287, No. 14. (10 April 2002), pp. 1840-1847.
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, No. 2. (April 2007), pp. 127-140.
Hearing Research, Vol. 226, No. 1-2. (April 2007), pp. 221-231.
Psychopharmacol Bull, Vol. 36 Suppl 2 (2002), pp. 123-132.
Am J Psychiatry, Vol. 164, No. 5. (1 May 2007), pp. 768-777.
Biomedecine & Pharmacotherapy, Vol. 60, No. 7. (August 2006), pp. 318-322.
Pharmacoepidemiol Drug Saf, Vol. 15, No. 10. (October 2006), pp. 719-725.
J Drugs Dermatol, Vol. 5, No. 10. (c 2006), pp. 1012-1014.
J Am Acad Dermatol, Vol. 56, No. 5. (May 2007), pp. 848-853.
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, No. 1. (February 2007), pp. 17-29.
Br J Pharmacol, Vol. 147 Suppl 1 (January 2006)
N Engl J Med (28 March 2007)
by Gary S S
Sachs, Andrew A A
Nierenberg, Joseph R R
Calabrese, Lauren B B
Marangell, Stephen R R
Wisniewski, Laszlo
Gyulai, Edward S S
Friedman, Charles L L
Bowden, Mark D D
Fossey, Michael J J
Ostacher, Terence A A
Ketter, Jayendra
Patel, Peter
Hauser, Daniel
Rapport, James M M
Martinez, Michael H H
Allen, David J J
Miklowitz, Michael W W
Otto, Ellen B B
Dennehy, Michael E E
Thase
Arch Gen Psychiatry, Vol. 64, No. 3. (March 2007), pp. 327-337.
Drug Safety, Vol. 30, No. 2. (2007), pp. 171-184.
Drug Safety, Vol. 30, No. 2. (2007), pp. 107-121.
CNS Drugs, Vol. 20, No. 3. (2006), pp. 187-198.
CNS Drugs, Vol. 19, No. 7. (2005), pp. 623-633.
N Engl J Med, Vol. 354, No. 6. (9 February 2006), pp. 579-587.
Am J Psychiatry, Vol. 161, No. 6. (June 2004), pp. 1066-1078.
Clin Pharmacol Ther, Vol. 81, No. 1. (2007), pp. 69-75.
N Engl J Med, Vol. 352, No. 11. (17 March 2005), pp. 1112-1120.
Curr Pharm Des, Vol. 11, No. 12. (2005), pp. 1475-1493.
Nature Reviews Drug Discovery, Vol. 4, No. 9. (01 September 2005), pp. 764-774.
Am J Psychiatry, Vol. 161, No. 5. (May 2004), pp. 826-835.
Ann Pharmacother, Vol. 32, No. 6. (June 1998), pp. 692-698.
Psychosomatics, Vol. 48, No. 1. (b 2007), pp. 1-9.
Psychosom Med, Vol. 67 Suppl 1 (n 2005)
Gerontology, Vol. 52, No. 1. (2006), pp. 45-50.
Journal of Cutaneous Medicine and Surgery, Vol. 9, No. 6. (December 2005), pp. 341-345.